Search: onr:"swepub:oai:DiVA.org:su-57718" >
GVHD after chemothe...
GVHD after chemotherapy conditioning in allogeneic transplanted mice
-
- Sadeghi, B. (author)
- Karolinska Institutet
-
Aghdami, N. (author)
-
- Hassan, Z. (author)
- Karolinska Institutet
-
show more...
-
Forouzanfar, M. (author)
-
- Rozell, B. (author)
- Karolinska Institutet
-
- Abedi-Valugerdi, Manuchehr (author)
- Karolinska Institutet,Stockholms universitet,Institutionen för biokemi och biofysik
-
- Hassan, M. (author)
- Karolinska Institutet
-
show less...
-
(creator_code:org_t)
- 2008-09-29
- 2008
- English.
-
In: Bone Marrow Transplantation. - : Springer Science and Business Media LLC. - 0268-3369 .- 1476-5365. ; 42:12, s. 807-818
- Related links:
-
https://www.nature.c...
-
show more...
-
https://urn.kb.se/re...
-
https://doi.org/10.1...
-
http://kipublication...
-
show less...
Abstract
Subject headings
Close
- GVHD is a major complication in allogeneic SCT. Available GVHD models are mainly based on radio-therapy-conditioning and/or immune deficient mice. GVHD models based on chemotherapy-based regimens remain poorly studied, despite 50% of all transplantations being chemotherapy based. Our aim was to develop a GVHD model using chemotherapy as conditioning. Female BALB/c (H-2Kd) were conditioned with BU-CY and transplanted with 2 x 10(7) BM and 3 x 10(7) spleen cells from either C57BL/6 (H-2Kb) mice ( allogeneic setting) or from male BALB/c to serve as a control group for regimen-related toxicity and engraftment. GVHD manifestations and histopathological changes were evaluated. Chimerism and donor T cells presence in skin, intestine and liver were studied using FACS-, FISH analysis and immunohistochemistry. Allogeneic transplanted mice developed lethal GVHD starting from day+7 with both histological and clinical signs. Donor T cells accumulated in recipient skin and intestine with GVHD progression. BM-failure, apoptosis and T-lymphocyte infiltration into target organs were significantly higher in allogeneic when compared with the syngeneic group. No toxicity or GVHD signs were observed in the syngeneic setting. We report a mouse model of GVHD using BU-CY conditioning that represents the most common myeloablative-conditioning regimen in clinical SCT. This model can be utilized to study the role of conditioning on mechanisms underlying GVHD.
Keyword
- BU
- CY
- chemotherapy conditioning
- GVHD
- mouse model
- hematopoietic stem cell transplantation
- versus-host-disease
- bone-marrow-transplantation
- total-body irradiation
- minor histocompatibility antigens
- stem-cell transplantation
- acute myeloid-leukemia
- t-cells
- in-vivo
- randomized-trial
- lethal graft
- NATURAL SCIENCES
- NATURVETENSKAP
Publication and Content Type
- ref (subject category)
- art (subject category)
Find in a library
To the university's database